Two live deployments. Two EMRs. Measured, live results — not projections.
A next-gen unified platform engineered for MSOs. Built on autonomous intelligence to Transform revenue performance from registration to reimbursement. Each module operates autonomously while sharing intelligence across the ecosystem for end-to-end revenue cycle optimization.
AI-Driven Front-End Automation & Access Intelligencei
AI Coding, Charge Capture & Revenue Integrity
AI-Powered Denial Prevention & Resolution
AI-Powered Enterprise Performance Intelligence

Multi-Site MSK Group
indexed denial-rate reduction vs. baseline

Multi-Site Cardiology Group
Denial rate at DenialShield pilot sites vs. baseline (~42% reduction)
−20.7% → −58.6% across the period
Flagged and fixed before submission
Bars: overall network denial rate. Orange line: claims under DenialShield. Baseline = CY 2025 average; data as of Jul 1, 2026.
These materials include certain statements, example results achieved, estimates, projections, and other forward-looking statements (collectively, the “Statements”). All Statements are provided for general informational, educational, and administrative purposes only and do not constitute guarantees of performance or outcomes. Past results and illustrative examples are not indicative of future results, and actual events or outcomes may differ materially from any predictions, projections, or prior results presented. Actual results for any organization or engagement depend on business, operational, and situation-specific circumstances, many of which are beyond the control of the Company and SCALE. Accordingly, no assurance can be given that any Statements, forecasts, or anticipated results will be achieved.